This study is for patients who have Stage IV metastatic colorectal cancer and their disease progressed after 2 lines of treatment with chemotherapy.
Protocol number: J04104
Type of cancer: Stage IV Metastatic Colorectal Cancer
Phase number: I
Summary: This is a phase I study for patients with Stage IV metastatic colorectal cancer who have had disease progression after 2 lines of chemotherapy. The purpose of the study is to find safe doses of sorafenib, in combination with Irinotecan and Cetuximab.